Indivior to appoint Lizabeth Zlatkus as non-executive director

Speciality pharmaceuticals firm Indivior will appoint Lizabeth Zlatkus as an independent non-executive director with effect from 1 September.

In a statement to the London Stock Exchange on Thursday, the company said Zlatkus will also become a member of its audit committee.

She spent a significant part of her career with Hartford Financial Services Group, one of the largest insurance and investment companies in the US, where she held a number of senior leadership positions including chief financial officer and chief risk officer.

Prior to joining Hartford, Zlatkus was a senior accountant with KPMG and is also a non-executive director of Legal & General Group and Boston Private Financial Holdings.

At 1613 BST, Indivior's share price was up 0.80p or 0.48% to 167.60p.